A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity

Journal of Biological Chemistry

Volumn 279, Issue 53, 2004, Pages 55147-55152

  Hertel, Johann ^a   Struthers, Heidi ^a   Horj, Christal Baird ^a   Hruz, Paul W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; DISEASES; ENZYME INHIBITION; ESTERS; GLUCOSE; OLIGOMERS; PROTEINS;

ASPARTYL PROTEASE; HIV INFECTION; HOMEOSTASIS; OOCYTE EXPRESSION SYSTEMS;

INITIATORS (CHEMICAL);

AMPRENAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ATAZANAVIR; BENZYLOXYCARBONYLHISTIDYLPHENYLALANYLPHENYLALANINE O ETHYL ESTER; BENZYLOXYCARBONYLHISTIDYLPHENYLALANYLPHENYLALANYL 4 BENZOYLPHENYLALANYLTYROSINE O ETHYL ESTER; DEOXYGLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INDINAVIR; INSULIN; LOPINAVIR; NELFINAVIR; PEPTIDE DERIVATIVE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; INSULIN RESPONSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT; TRANSPORT KINETICS; XENOPUS LAEVIS;

ADIPOCYTES; ANIMALS; ASPARTIC ENDOPEPTIDASES; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HIV PROTEASE INHIBITORS; INDINAVIR; KINETICS; LIGHT; MODELS, CHEMICAL; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; OLIGOPEPTIDES; OOCYTES; PEPTIDES; PROTEIN ISOFORMS; RATS; XENOPUS LAEVIS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; XENOPUS LAEVIS;

EID: 11244320362     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M410826200     Document Type: Article

References (23)

1. Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., and Holmberg, S. D. (1998) N. Engl. J. Med. 338, 853-860
2. Carr, A., Samaras, K., Burton, S., Law, M., Freund, I., Chisholm, D. J., and Cooper, D. A. (1998) AIDS 12, F51-F58
3. Mulligan, K., Grunfeld, C., Tai, V. W., Algren, H., Pang, M., Chernoff, D. N., Lo, J. C., and Schambelan, M. (2000) J. Acquired Immune Defic. Syndr. 23, 35-43
4. Noor, M., Lo, J. C., Mulligan, K., Halvorsen, R., Schwarz, J. M., Shambelan, M., and Grunfeld, C. (2000) Antiviral Therapy 5, 8
5. Murata, H., Hruz, P. W., and Mueckler, M. (2000) J. Biol. Chem. 275, 20251-20254
6. Hruz, P., Murata, H., Qiu, H., and Mueckler, M. (2002) Diabetes 51, 937-942
7. Noor, M. A., Seneviratne, T., Aweeka, F. T., Lo, J. C., Schwarz, J. M., Mulligan, K., Schambelan, M., and Grunfeld, C. (2002) AIDS 16, F1-F8
8. Cammalleri, C., and Germinario, R. J. (2003) J. Lipid Res. 44, 103-108
9. Schutt, M., Meier, M., Meyer, M., Klein, J., Aries, S. P., and Klein, H. H. (2000) Diabetologia 43, 1145-1148
10. Caron, M., Auclair, M., Vigouroux, C., Glorian, M., Forest, C., and Capeau, J. (2001) Diabetes 50, 1378-1388
11. Xu, A., Yin, S., Wong, L., Chan, K. W., and Lam, K. S. (2004) Endocrinology 145, 487-494
12. Murata, H., Hruz, P., and Mueckler, M. (2002) AIDS 16, 859-863
13. Holman, G. D., Kozka, I. J., Clark, A. E., Flower, C. J., Saltis, J., Habberfield, A. D., Simpson, I. A., and Cushman, S. W. (1990) J. Biol. Chem. 265, 18172-18179
14. Inouye, K., Voynick, I. M., Delpierre, G. R., and Fruton, J. S. (1966) Biochemistry 5, 2473-2483
15. Keller, K., Strube, M., and Mueckler, M. (1989) J. Biol. Chem. 264, 18884-18889
16. Woerle, H. J., Mariuz, P. R., Meyer, C., Reichman, R. C., Popa, E. M., Dostou, J. M., Welle, S. L., and Gerich, J. E. (2003) Diabetes 52, 918-925
17. Schwarcz, S. K., Hsu, L. C., Vittinghoff, E., and Katz, M. H. (2000) Am. J. Epidemiol. 152, 178-185
18. Aiello, L. P., Wessling-Resnick, M., and Pilch, P. F. (1986) Biochemistry 25, 3944-3950
19. Wang, S., Mulvey, R., Laing, N., Leet, J., Flint, J., and Parker, R. A. (2002) Antiviral Therapy 7, L6 (abstr.)
20. Murphy, R., Pokrovsky, V., and Rozenbaum, W. (2003) in Proceedings and Abstracts of the 10th Conference on Retroviruses and Opportunistic Infections (Boston), February 10-14, 2003, Abstract 555, Foundation for Retrovirology and Human Health, Alexandria, VA
21. Smith, R. M., Charron, M. J., Shah, N., Lodish, H. F., and Jarett, L. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6893-6897
22. Wang, W., Hansen, P. A., Marshall, B. A., Holloszy, J. O., and Mueckler, M. (1996) J. Cell Biol. 135, 415-430
23. Koster, J. C., Remedi, M. S., Qiu, H., Nichols, C. G., and Hruz, P. W. (2003) Diabetes 52, 1695-1700